Literature DB >> 15949774

Trend in methodological quality of randomised clinical trials in low back pain.

B W Koes1, A Malmivaara, M W van Tulder.   

Abstract

During the past decades, the number of published randomised clinical trials evaluating the efficacy of conservative treatments for low back pain has substantially increased. At the same time several initiatives were undertaken in order to improve the methodological quality of published randomised clinical trials, also in the field of low back pain. We investigated how the methodological quality of randomised clinical trials in the field of low back pain developed over time since the first published trial in 1961. Methodological scores of 269 RCTs included in 15 Cochrane reviews of conservative treatment for low back pain were compared. Overall many trials showed methodological shortcomings. The median overall quality scores ranged from 36 to 82% depending on the type of intervention. There were no improvements in median overall methodological quality over time from 1960 to 2004. Improvements were apparent for a few validity criteria only.

Entities:  

Mesh:

Year:  2005        PMID: 15949774     DOI: 10.1016/j.berh.2005.02.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  2 in total

Review 1.  Trends over time in the size and quality of randomised controlled trials of interventions for chronic low-back pain.

Authors:  Nicholas Henschke; Ton Kuijpers; Sidney M Rubinstein; Marienke van Middelkoop; Raymond Ostelo; Arianne Verhagen; Bart W Koes; Maurits W van Tulder
Journal:  Eur Spine J       Date:  2011-10-27       Impact factor: 3.134

2.  Research priorities for non-pharmacological therapies for common musculoskeletal problems: nationally and internationally agreed recommendations.

Authors:  Nadine E Foster; Krysia S Dziedzic; Danielle A W M van der Windt; Julie M Fritz; Elaine M Hay
Journal:  BMC Musculoskelet Disord       Date:  2009-01-09       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.